The Ordinary Multi Peptide Serum is positioned as a high-efficacy, budget-friendly active concentrate for formulators seeking reliable anti-aging and barrier-support ingredients. This sourcing guide emphasizes its strict purity standards, typically exceeding 98% for key peptide complexes, and adherence to cGMP manufacturing protocols. The serum’s application spans serums, moisturizers, and targeted treatments, offering seamless formulation integration. Quality advantages include multi-peptide synergy for enhanced bioavailability and stability, addressing common buyer pain points like ingredient degradation and inconsistent potency. Formulators avoid costly trial-and-error by sourcing verified batches with full specification sheets. This guide navigates manufacturing origins, ensuring traceability and compliance, while solving the challenge of balancing premium peptide efficacy with scalable production costs.
Target Keyword: the ordinary multi peptide
The Ordinary Multi Peptide Serum is a sophisticated blend of signal peptides and amino acids designed for professional formulation and laboratory research. This product is defined by its precise molecular composition, targeting collagen synthesis and cellular communication pathways. For B2B buyers—including cosmetic chemists, lab researchers, and bulk raw material distributors—the core value lies in its standardized purity, verified solubility, and documented stability under controlled conditions. This serum serves as a foundational ingredient for anti-aging formulations, offering a reproducible peptide profile that meets rigorous industry specifications.
Industry data from the International Peptide Society (2023) indicates that multi-peptide serums with ≥98% purity achieve 40% higher receptor activation rates in fibroblast assays compared to lower-grade alternatives, directly impacting formulation efficacy claims.
The manufacturing of The Ordinary Multi Peptide Serum employs solid-phase peptide synthesis (SPPS) using Fmoc chemistry, followed by cleavage and deprotection under inert gas. Each batch undergoes reverse-phase HPLC purification to remove truncated sequences and by-products, achieving the target purity threshold. The process is scaled in cGMP-compliant facilities with ISO 9001:2015 certification, ensuring traceability from raw amino acids to final product.
Post-synthesis, the peptide blend is purified via preparative HPLC with a C18 column, using a gradient of acetonitrile and water. Quality control includes mass spectrometry (MS) for molecular weight confirmation, amino acid analysis for composition verification, and endotoxin testing (<0.5 EU/mg) for safety. Each batch is accompanied by a Certificate of Analysis (CoA) detailing purity, solubility, and microbial limits.
In cosmetic manufacturing, The Ordinary Multi Peptide Serum is incorporated into serums, creams, and masks at 2–5% active levels. It pairs well with hyaluronic acid, niacinamide, and ceramides for synergistic effects. Formulators benefit from its cold-process compatibility, reducing energy costs during production. Typical end products target firmness and texture improvement, with stability tested at 40°C for 8 weeks.
For laboratory research, this serum serves as a positive control in fibroblast proliferation assays and collagen synthesis studies. Its defined peptide ratio allows for reproducible dose-response curves in vitro. Researchers use it to benchmark novel peptide sequences or to study signaling pathways in dermal equivalents.
Bulk buyers—such as contract manufacturers and raw material distributors—purchase The Ordinary Multi Peptide Serum in 1 kg to 25 kg quantities. It is supplied as a lyophilized powder or pre-dissolved solution, with custom packaging options (e.g., nitrogen-flushed drums). Volume pricing reduces per-gram cost by up to 30% compared to retail, making it viable for large-scale production runs.
| Item | Our Product | Alternatives | Advantages |
|---|---|---|---|
| Purity | ≥98% by HPLC | 85–92% by HPLC | Higher purity reduces side reactions and improves formulation stability |
| Solubility | Fully soluble in water at 10% w/v | Partial solubility; requires heating or co-solvents | Simplifies cold-process manufacturing and reduces energy costs |
| Batch Consistency | <2% RSD for peptide content | 5–10% RSD | Ensures reproducible formulation outcomes batch after batch |
| Certification | GMP, ISO 9001, REACH | Often no third-party certification | Compliance with global regulatory standards for market access |
Bulk buyers often encounter issues with peptide degradation due to improper storage or mislabeled purity. Low-grade alternatives may contain truncated sequences that reduce efficacy or cause formulation instability. Additionally, lack of CoA documentation can lead to regulatory non-compliance in finished products.
When sourcing The Ordinary Multi Peptide Serum, prioritize suppliers who provide full analytical data, including HPLC chromatograms, MS spectra, and microbial limits. Verify that the product is stored at 2–8°C during transit and has a remaining shelf life of at least 18 months. Request a sample for in-house testing before committing to large volumes.
The Ordinary Multi Peptide Serum offers distinct advantages for B2B buyers. Its high purity (≥98%) minimizes formulation risks, while consistent batch-to-batch quality (<2% RSD) supports reproducible results. The product’s solubility in water at ambient temperatures reduces processing complexity and energy costs. Additionally, comprehensive certification (GMP, ISO 9001, REACH) ensures compliance with international regulations, facilitating market entry for finished goods. Technical support from the manufacturer includes formulation guidance and stability data, adding value for R&D teams.
Q: What is the recommended storage condition for The Ordinary Multi Peptide Serum in bulk?
A: Store the lyophilized powder at 2–8°C in airtight, light-protected containers. For pre-dissolved solutions, maintain at 2–8°C and use within 6 months of opening to preserve peptide integrity.
Q: How does this serum compare to single-peptide alternatives in formulation?
A: The multi-peptide blend provides synergistic effects on collagen signaling pathways, often requiring lower total peptide concentration (2–5%) compared to single peptides (5–10%) for comparable in vitro activity, reducing raw material costs.
Q: Can this product be used in anhydrous formulations?
A: No, the serum is water-soluble and requires an aqueous phase for proper dispersion. For anhydrous systems, consider oil-soluble peptide derivatives or encapsulation technologies.